Form 4 for CVKD Cadrenal Therapeutics, Inc.
Accepted 2024-02-12 00:00:00 ET · period of report 2023-10-23 · accession 0001213900-24-012837 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-12 | 2023-10-23 | CVKD | Pham Quang X | CEO, COB, Dir, 10% | G - Gift | $0.00 | -85.0K | 3.33M | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-23 | G | D | 85,000 | $0.00 | 3,325,000 | D | — | — | (F1) On October 23, 2023, Quang Pham transferred an aggregate of 85,000 shares of common stock to three non-for-profit organizations, as gifts for no value received, pursuant to a written agreement with each of the three organizations signed by a representative of each such organization and Mr. Pham. |